HA
TMO icon

Harfst & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Harfst & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
3,968
+209
+6% +$100K 0.31% 61
2026
Q1 		$1.85M Buy
3,759
+304
+9% +$165K 0.33% 59
2025
Q4 		$2M Sell
3,455
-28
-0.8% -$15.8K 0.36% 46
2025
Q3 		$1.69M Buy
3,483
+53
+2% +$24.7K 0.31% 62
2025
Q2 		$1.39M Buy
3,430
+2,221
+184% +$929K 0.29% 72
2025
Q1 		$602K Buy
+1,209
New +$655K 0.14% 91

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Harfst & Associates's TMO Position: Q2 2026 in Review

Harfst & Associates increased its Thermo Fisher Scientific (TMO) stake by 5.6% in Q2 2026, buying an estimated $100K and bringing the position to 3,968 shares worth $1.99M. The position accounts for 0.31% of the portfolio, ranked #61.

Harfst & Associates first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $2M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Harfst & Associates held 3,968 shares of Thermo Fisher Scientific worth $1.99M as of Q2 2026.
  • Harfst & Associates bought 209 Thermo Fisher Scientific shares in Q2 2026, an estimated $100K.
  • Thermo Fisher Scientific made up 0.31% of Harfst & Associates's portfolio in Q2 2026, its #61 holding.
  • Harfst & Associates first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • Harfst & Associates's Thermo Fisher Scientific position peaked at $2M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Harfst & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.